| PMID |
14625013 ( ![]() ![]() ![]() ) |
|---|---|
| Title | Zinc amplifies mSOD1-mediated toxicity in a transgenic mouse model of amyotrophic lateral sclerosis. |
| Abstract | Transgenic mice overexpressing the human mutated form (G93A) of Cu,Zn-superoxide dismutase (mSOD1) develop motor neuron degeneration resembling amyotrophic lateral sclerosis. In vitro studies have shown that mSOD1-induced, reactive oxygen species-mediated apoptosis of motor neurons depends on the presence of copper and the relative absence of zinc. Oral intake of zinc sulphate induces the expression of metallothioneins, enzymes that decrease oxidative stress, and leads to higher serum zinc, and lower copper levels. We therefore tested the effect of chronic oral administration of zinc sulfate (0.075 and 0.375 g/kg) on disease onset and survival of mSOD1 transgenic mice. We observed that zinc sulfate, rather than prolonging survival, decreased survival. We conclude that zinc sulfate amplifies the mSOD1 transgenic mouse phenotype. This finding may shed more light on the role of zinc in mSOD1-mediated toxicity. Neurosurgery, G.03.228, University Medical Center Utrecht, P.O. Box 85500, 3508 GA, Utrecht, The Netherlands. |
NOTE: Color highlight is limited to the abstract and SciMiner text-mining mode. If you see much more identified targets below from "Targets by SciMiner Summary" and "Targets by SciMiner Full list", they may have been identified from the full text.
Targets by SciMiner Summary
| HUGO ID | Symbol | Target Name | #Occur | ActualStr |
|---|---|---|---|---|
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | 30 | SOD1 | mSOD1 | superoxide dismutase | |
Targets by SciMiner Full list
| HUGO ID | Symbol | Name | ActualStr | Score | FlankingText |
|---|---|---|---|---|---|
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | mSOD1 | 1.4 | human mutated form (G93A) G93A of Cu Zn-superoxide dismutase (mSOD1) mSOD1 develop motor neuron degeneration resembling amyotrophic lateral sclerosis |
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | mSOD1 | 1.4 | 0.375 g/kg) g kg on disease onset and survival of mSOD1 transgenic mice |
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | mSOD1 | 1.4 | We conclude that zinc sulfate amplifies the mSOD1 transgenic mouse phenotype |
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | SOD1 | 1.4 | but mutations in the gene encoding Cu Zn-superoxide dismutase (SOD1) SOD1 are found in approximately 2% of ALS patients 12 |
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | SOD1 | 1.4 | Transgenic mice overexpressing human SOD1 carrying the G93A mutation (mSOD1) mSOD1 develop a rapidly progressive |
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | mSOD1 | 1.4 | Transgenic mice overexpressing human SOD1 carrying the G93A mutation (mSOD1) mSOD1 develop a rapidly progressive muscular weakness due to motor neuron |
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | SOD1 | 1.4 | SOD1 is a metalloenzyme that catalyzes the conversion of superoxide to |
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | mSOD1 | 1.4 | Such gained properties of mSOD1 include increased formation of free radicals with hydrogen peroxide as |
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | SOD1 | 1.4 | In vitro studies showed that mutations in SOD1 destabilize the protein and decrease the affinity of SOD1 for |
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | SOD1 | 1.4 | in SOD1 destabilize the protein and decrease the affinity of SOD1 for zinc up to 50-fold compared to the wild type |
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | SOD1 | 1.4 | Zinc-deficient SOD1 leads to an increase in nitrotyrosine formation and induces apoptosis |
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | SOD1 | 1.4 | This toxicity required copper to be bound to SOD1 and was not present when SOD1 was replete with zinc |
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | SOD1 | 1.4 | to be bound to SOD1 and was not present when SOD1 was replete with zinc 3 |
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | mSOD1 | 1.4 | upregulation of MT's is seen in the spinal cord of mSOD1 transgenic mice 11 and reduction of MT-I and -II significantly |
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | mSOD1 | 1.4 | and reduction of MT-I and -II significantly reduces survival of mSOD1 transgenic mice 10 |
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | SOD1 | 1.4 | expression of MT's would be neuroprotective in transgenic high-copy human SOD1 G93A mice (Jackson Jackson Laboratory Bar Harbor MN |
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | SOD1 | 1.4 | G93A male SOD1 mice were crossbred with non-transgenic Balb/C Balb C females |
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | SOD1 | 1.4 | Prior to the G93A SOD1 experiment the effect of high dose zinc sulphate on hematological |
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | SOD1 | 1.4 | In the G93A SOD1 mice the hind-paw extension reflex test was performed 5 days |
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | mSOD1 | 1.4 | In untreated mSOD1 transgenic mice a similar though clearly more intense staining pattern |
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | mSOD1 | 1.4 | in immunoreactivity for MT's were observed between zinc-treated and untreated mSOD1 transgenic mice ( Figs 2B C |
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | mSOD1 | 1.4 | would attenuate motor neuron death and thus extend survival of mSOD1 transgenic mice |
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | mSOD1 | 1.4 | zinc sulphate (0.375 0.375 g/kg) g kg decreased survival of mSOD1 transgenic mice |
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | mSOD1 | 1.4 | level in the spinal cord of both treated and untreated mSOD1 transgenic mice but a further upregulation of MT in the |
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | mSOD1 | 1.4 | The selective toxicity in mSOD1 transgenic mice may be due to enhanced motor neuron death |
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | mSOD1 | 1.4 | raises two related questions why is zinc not neuroprotective in mSOD1 transgenic mice and why does it even appear to accelerate |
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | mSOD1 | 1.4 | maximum in the spinal cord (and and intestinal wall of mSOD1 transgenic mice 11 so that a further upregulation cannot be |
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | mSOD1 | 1.4 | direct toxic effect of zinc on motor neurons 18 of mSOD1 transgenic mice |
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | superoxide dismutase | 1.0 | transgenic mice overexpressing the human mutated form g93a of cu zn superoxide dismutase msod1 develop motor neuron degeneration resembling amyotrophic lateral sclerosis. |
| 11179 | SOD1 | superoxide dismutase 1, soluble (amyotrophic lateral sclerosis 1 (adult)) | superoxide dismutase | 1.0 | the exact etiology of the disease is unknown but mutations in the gene encoding cu zn superoxide dismutase sod1 are found in approximately 2% of als patients [ 12 ]. |